APIs para pesquisa e impurezas
Os Ingredientes Farmacêuticos Ativos (APIs) são as substâncias nos medicamentos responsáveis por seus efeitos terapêuticos. Nesta seção, você encontrará uma ampla variedade de APIs destinados a uso em pesquisa. Esses compostos são essenciais para o desenvolvimento, teste e validação de novas formulações farmacêuticas. Na CymitQuimica, oferecemos APIs de alta qualidade para apoiar a pesquisa em descoberta e desenvolvimento de medicamentos.
Subcategorias de "APIs para pesquisa e impurezas"
- Aminoácidos e Derivados(12.440 produtos)
- Antraquinonas e Derivados(407 produtos)
- Derivados de Benzimidazol e Imidazol(10.464 produtos)
- Derivados das Benzodiazepinas(335 produtos)
- Carboidratos e Glicoconjugados(5.388 produtos)
- Ésteres e Derivados(42.306 produtos)
- Ácidos Graxos e Derivados Lipídicos(32.486 produtos)
- Flavonoides e Polifenóis(17.100 produtos)
- Radicais Livres e Agentes Oxidantes/Redutores(214 produtos)
- Cetonas e Derivados(2.692 produtos)
- Antibióticos Naturais e Semissintéticos(6.409 produtos)
- Nitrilas e Derivados Ciano(3.070 produtos)
- Nitrosaminas e Derivados(55 produtos)
- Nucleosídeos e Nucleotídeos(3.492 produtos)
- Fosfatos e Fosfonatos Orgânicos(1.203 produtos)
- Sulfonatos e Sulfatos Orgânicos(10.451 produtos)
- Compostos Organometálicos(4.425 produtos)
- Outros(6.340 produtos)
- Peptídeos e Proteínas(3.164 produtos)
- Polímeros e Derivados(100 produtos)
- Derivados de Purinas e Pirimidinas(8.974 produtos)
- Derivados de Quinazolina e Quinolina(66.217 produtos)
- Quinonas e Derivados(24.378 produtos)
- Sais e Derivados de API(92.894 produtos)
- Esteroides e Derivados(4.987 produtos)
- Sulfonamidas e Derivados(2.607 produtos)
- Terpenoides e Derivados(3.860 produtos)
- Tiazolidinedionas e Tiopiranos(2.755 produtos)
- Compostos β-Adrenérgicos(231 produtos)
Exibir 21 mais subcategorias
Foram encontrados 66870 produtos de "APIs para pesquisa e impurezas"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Fluticasone furoate impurity F
Fluticasone furoate impurity F is a synthetic, high-purity, pharmacopoeia grade drug product. It has been developed for research and development purposes only. Impurity standard: Fluticasone furoate impurity F is a metabolite of fluticasone furoate. Synthetic: Fluticasone furoate impurity F is a synthetic compound that has been custom synthesized to meet your requirements. Drug Development: Fluticasone furoate impurity F has been developed as a drug product to be used in the development of new drugs. Metabolism Studies: Fluticasone furoate impurity F can be used in metabolism studies and analytical determinations.END>>Pureza:Min. 95%Amoxicillin impurity 33
CAS:Amoxicillin impurity 33 is a drug product that is used as an analytical standard for impurities in amoxicillin. It is a natural metabolite of amoxicillin, which is obtained from the fermentation of bacteria. This metabolite has been found to be present in human urine and has been detected in commercial preparations of amoxicillin. Amoxicillin impurity 33 is a white powder with a melting point of about 180-185°C.Pureza:Min. 95%Biotin impurity E
Biotin impurity E is a metabolite of biotin that is produced by the metabolism of biotin in humans. It can be detected in urine, saliva, and blood. Biotin impurity E has been shown to be naturally occurring and is a metabolite of biotin found as an impurity in pharmaceutical products. The purity of this drug product was determined to be 98% by HPLC analysis with a detection limit of 0.1%.
Fórmula:C34H44N4O6S2Pureza:Min. 95%Peso molecular:668.9 g/molNaltrexone impurity A
CAS:Produto ControladoNaltrexone impurity A is a synthetic, high-purity drug product that is used as an analytical reference standard in the development and manufacture of pharmaceuticals. It is also used as a pharmacopoeia reference standard and to study metabolism. Naltrexone impurity A has been shown to be a major metabolite of naltrexone and can be found in the urine at concentrations of 1-2% following oral administration. This impurity is not active when given orally, but may have activity if injected intravenously or intramuscularly.
Fórmula:C17H17NO5Pureza:Min. 95%Cor e Forma:PowderPeso molecular:315.32 g/mol3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
CAS:3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one is an antibacterial agent that inhibits bacterial growth by binding to the 50S ribosomal subunit. It is a white crystalline powder that is soluble in methanol and acetonitrile. 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4 - one binds to the ribosome and interferes with protein synthesis by inhibiting the release of aminoacyl tRNA from the ribosome. The drug has been shown to have antibacterial activity against Gram positive and Gram negative bacteria. 3-(2) Chloroethyl)-2-methyl 6,7Fórmula:C11H15ClN2OPureza:Min. 95 Area-%Cor e Forma:PowderPeso molecular:226.7 g/mol3-[[[2-[(Diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide hydrochloride
CAS:3-[[[2-[(Diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide hydrochloride is a Custom synthesis, drug product, Metabolite, Synthetic, Drug development, Impurity standard, Metabolism studies, API impurity, Natural and pharmacopoeia. 3-[[[2-[(Diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide hydrochloride has CAS No. 76833-47-1 and is a High purity.Fórmula:C8H14N6S2·HClPureza:Min. 95%Cor e Forma:PowderPeso molecular:294.83 g/molEpirubicin impurity G
CAS:Epirubicin impurity G is a synthetic research and development impurity standard that is used in the manufacture of drug products, as well as in the development of new drugs. Epirubicin impurity G is a metabolite of epirubicin and has been shown to be an active inhibitor of DNA synthesis. Epirubicin impurity G may also have potential as an analytical standard for HPLC analysis.Fórmula:C54H58N2O22Pureza:Min. 95%Peso molecular:1,087 g/molTopiramate N-methyl impurity
CAS:Topiramate is a drug used to treat epilepsy and weight loss. The N-methyl impurity is a synthetic compound that is an impurity in the drug product. The impurity was synthesized by reacting 4-hydroxybenzaldehyde with methylamine in the presence of triethylamine. It has been shown to be not metabolized, but excreted unchanged in urine.Fórmula:C13H23NO8SPureza:Min. 95%Cor e Forma:Colourless LiquidPeso molecular:353.39 g/molGuaifenesin EP impurity C
CAS:This is a metabolite of guaifenesin, and it is an impurity in the EP guaifenesin. It can be custom synthesized for research and development purposes. The purity of this product is high, and it can be used as an analytical standard or a drug product.
Fórmula:C20H26O7Pureza:Min. 95 Area-%Cor e Forma:Colorless Clear LiquidPeso molecular:378.42 g/mol4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine
CAS:4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine is an impurity standard of the drug product. It is a high purity synthetic compound with a niche in pharmacopoeia and drug development. 4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine has been shown to be a metabolite of the natural product.Fórmula:C6H5IN4Pureza:Min. 97 Area-%Cor e Forma:PowderPeso molecular:260.04 g/mol(S)-Ethyl 2-ethoxy-4-[[[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]amino]carbonyl]methyl]benzoate
CAS:(S)-Ethyl 2-ethoxy-4-[[[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]amino]carbonyl]methyl]benzoate is an intermediate in the synthesis of repaglinide. It is a reagent that reacts with ethylamine and carbodiimide hydrochloride to form a urea derivative. This urea derivative is then reacted with filtration to give the desired product, which is recrystallized from dichloromethane solution. The (S)-ethyl 2-ethoxy-4-[(N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]amino)carbonyl]-methyl benzoate can be converted into the ester, phenylacetic acid, through hydrolytic reaction.Fórmula:C29H40N2O4Pureza:Min. 95%Cor e Forma:White PowderPeso molecular:480.64 g/mola-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-α-ethyl-3,4-dimethoxy-benzeneacetonitrile
CAS:a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-alpha-ethyl-3,4-dimethoxy-benzeneacetonitrile is a new inhibitor of the human p glycoprotein (Pgp). It has been shown to inhibit the function of Pgp in vitro and in vivo. This compound is structurally related to other known inhibitors of Pgp, such as verapamil. The topological similarity between these compounds can be rationalized by the fact that they all have a two methyleneoxy ring system with an alpha ethyl side chain. The substructural similarity can be explained by the presence of three contiguous hydroxyl groups on the benzene ring and two methyl groups on the alpha ethyl side chain.Fórmula:C26H36N2O4Pureza:Min. 95%Peso molecular:440.58 g/mol2-[4-(2-Methylpropanoyl)phenyl] propanoic acid
CAS:2-[4-(2-Methylpropanoyl)phenyl] propanoic acid is a pharmaceutical intermediate that is used for the production of carprofen. It has been found to be an analytical method for the determination of 4-hydroxybenzoic acid and 4-isobutylacetophenone. The compound is analyzed by chromatographic methods and electrophoresis methods. The optimization of the solvent composition, flow rate, and impurities during the synthesis process are also studied in this research. 2-[4-(2-Methylpropanoyl)phenyl] propanoic acid has been found to be a meaningful validation of analytical methods for medicines, with an impurity limit of 0.1%.Fórmula:C13H16O3Pureza:Min. 98 Area-%Cor e Forma:PowderPeso molecular:220.26 g/molN-[[2'-(2H-Tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-Valine
CAS:N-[[2'-(2H-Tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-Valine is a synthetic, nonstandardized HPLC standard that is used in drug development and metabolism studies. It is not available as a natural product, but can be made synthetically. N-[[2'-(2H-Tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-Valine has the CAS No. 676129-92-3 and impurity standards are available for this compound.
Fórmula:C19H21N5O2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:351.4 g/molCefazolin impurity A
CAS:Cefazolin impurity A is a by-product in the synthesis of Cefazolin, which is a drug product. It has CAS No. 30246-33-4 and is used as an impurity standard for analytical purposes. The Impurity Standard is also known as Metabolite A. Research and Development (R&D) studies are needed to identify the appropriate analytical impurities for this API, which will be reported on Pharmacopoeia's List of Impurities for reference. The high purity and custom synthesis of this API makes it ideal for use in R&D studies, HPLC standards, or niche markets.
CAS No.: 30246-33-4
Synonyms: Metabolite A
Formula: C11H14N2O5S
Molecular weight: 289.24 g/mol
Appearance: white solid powderFórmula:C11H12N4O3S3Pureza:Min. 95%Cor e Forma:PowderPeso molecular:344.44 g/molCalcipotriol EP Impurity G
Calcipotriol EP Impurity G is an impurity in calcipotriol, which is a drug product. Calcipotriol EP Impurity G has a CAS number of 126825-26-3 and is a natural metabolite of calcipotriol. It is also known as calcipotriol EP Impurity G or calcipotriol EPIG. It has been shown to be an analytical impurity in calcipotriol, and it has been detected by HPLC analysis. Calcipotriol EP Impurity G can be used for research and development, as well as for the production of pharmacopoeia standards.Fórmula:C54H78O5Pureza:Min. 95 Area-%Cor e Forma:White PowderPeso molecular:807.19 g/molOlmesartan EP Impurity C
CAS:Olmesartan medoxomil is a prodrug that is metabolized to the active form, olmesartan, in the liver. The esters of olmesartan medoxomil are metabolized by hydrolysis and by esterases. The most common side effects of olmesartan medoxomil are headache, dizziness, fatigue, nausea and diarrhea. Olmesartan medoxomil is used for the treatment of high blood pressure in adults. This drug also has anti-inflammatory properties due to its inhibition of prostaglandin synthesis.
Fórmula:C29H28N6O5Pureza:Min. 95%Cor e Forma:White Off-White PowderPeso molecular:540.57 g/mol5-Benzoyl-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-2,3-dihydro-1H-pyrrolizine-1-carboxamide, racemic
CAS:5-Benzoyl-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-2,3-dihydro-1H-pyrrolizine-1-carboxamide is a drug product that is used in research and development. It is a synthetic compound with niche applications. It has been shown to be metabolized in animal studies and the metabolism pathways have been elucidated. The analytical impurity standard for this drug product is 5-(benzoylamino)-N-[2-(hydroxymethyl)propanoyl]-2,3,-dihydro-1H-pyrrolizine-1 -carboxamide. This compound can be custom synthesized and also has an HPLC standard available.Fórmula:C19H22N2O5Pureza:Min. 95%Cor e Forma:PowderPeso molecular:358.39 g/mol3-[Benzyl(methyl)amino]-1-phenylpropan-1-one
CAS:3-[Benzyl(methyl)amino]-1-phenylpropan-1-one is a glycol that has been optimized for synthesis. It is used in research to prepare nitrates, which are stoichiometric reagents. Dimethylformamide and dioxane are reagents that can be used for this purpose. The yields of 3-[Benzyl(methyl)amino]-1-phenylpropan-1-one depend on the irradiation time, so it is important to maximize this variable. Phase extraction can be used to purify the product after irradiation. 3-[Benzyl(methyl)amino]-1-phenylpropan-1-one may act as a receptor modulator by binding to G protein coupled receptors and activating them or inhibiting their activation. This drug has also been shown to inhibit the production of nitric oxide, which is an important mediator in inflammation and vascular diseases such as hypertension and atherosclerosis.Fórmula:C17H19NOPureza:Min. 95%Cor e Forma:PowderPeso molecular:253.34 g/mol3-Oxo-4-aza-5a-androst-1-ene-17b-carboxylic acid
CAS:3-Oxo-4-aza-5a-androst-1-ene-17b-carboxylic acid is a covalently bonded prodrug that is metabolized to its active form, finasteride, in the body. It has been shown to have physiological activities such as skin permeation and cell growth. 3-Oxo-4-aza-5a-androst-1-ene 17b carboxylic acid also has immunotherapy properties and can be conjugated with other compounds for use in cancer treatment.Fórmula:C19H27NO3Pureza:Min. 98 Area-%Cor e Forma:PowderPeso molecular:317.42 g/mol
![3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFC20229.webp&w=3840&q=75)
![3-[[[2-[(Diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FID58079.webp&w=3840&q=75)
![4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFA170208.webp&w=3840&q=75)
![(S)-Ethyl 2-ethoxy-4-[[[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]amino]carbonyl]methyl]benzoate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIE27701.webp&w=3840&q=75)
![a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-α-ethyl-3,4-dimethoxy-benzeneacetonitrile](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FID145566.webp&w=3840&q=75)
![2-[4-(2-Methylpropanoyl)phenyl] propanoic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIM15852.webp&w=3840&q=75)
![N-[[2'-(2H-Tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-Valine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIT106480.webp&w=3840&q=75)
![5-Benzoyl-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-2,3-dihydro-1H-pyrrolizine-1-carboxamide, race…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIB58063.webp&w=3840&q=75)
![3-[Benzyl(methyl)amino]-1-phenylpropan-1-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIB158700.webp&w=3840&q=75)
